Alpha Lipoic Acid

Alpha Lipoic Acid

Best for

Ease neuropathic pain

Large effect, needs confirmation 600–1800 mg/day 9–16 weeks 1 meta-analysis, n=128 #4 of 5 studied

Alpha lipoic acid provides likely real but unnoticeable relief of neuropathy symptoms in people with symptomatic diabetic polyneuropathy, with average improvements too small for most users to clearly feel.

Median effective dose, most-studied outcomes

  • Ease neuropathy symptoms 600 mg 16–208 wk
  • Ease neuropathic pain 600 mg 3–16 wk
Full protocol, 2 outcomes

Risk, worst reported severity

  • serious adverse events (any) severe
  • renal failure severe
  • doxorubicin major
  • 5-fluorouracil major
All 18 events and interactions

What alpha lipoic acid actually does

Outcome Effect Evidence Dose Time Rank
Modest benefits 1
Ease neuropathy symptoms Likely real but unnoticeable Neuropathy can cause pain, numbness, tingling, weakness, and changes in sensation.
trivial
4 meta-analyses 6 papers · n=4.7k 600–1800 mg 4–208 wk #4 /12
Worth watching 1
Ease neuropathic pain Large effect, needs confirmation Neuropathic pain comes from damaged or irritated nerves and can feel burning, shooting, or electric.
large
1 meta-analysis 3 papers · n=128 600–1800 mg 9–16 wk #4 /5

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

For neuropathy symptoms and nerve pain, the most useful oral trial dose is 600 mg daily. Studies also tested 600 to 1,800 mg daily, but higher doses do not create a clear reason to expect proportionally better, noticeable relief.23 The evidence base tracks symptoms over weeks to months, so this is not an as-needed pain reliever.23

When and how long

Use it consistently each day rather than saving it for painful days, since the clinical protocols assessed ongoing daily use.23 The pivotal studies establish daily dose and duration more clearly than a best time of day, so choose a time you can stick with and follow the product label or clinician guidance if stomach upset becomes an issue.23

Forms & standardisation

Look for a label that states the actual amount of alpha lipoic acid per serving. The strongest neuropathy trial coverage comes from conventional alpha lipoic acid preparations, not from R-alpha lipoic acid alone, so claims that one isolated form is clinically superior run ahead of the main trial record.23

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Ease neuropathy symptoms 600–1,800 mg 600 mg 16–208 wk 6 papers 8 sig. endpoints
Ease neuropathic pain 600–1,800 mg 600 mg 3–16 wk 3 papers 2 sig. endpoints

Adverse events and drug interactions

Safety events

serious adverse events (any) severe
renal failure severe
glomerulonephritis / proteinuria severe
Gastric cancer (severe adverse event) severe
Duodenitis (severe adverse event, placebo group) severe
Injury of cartilage (severe adverse event, placebo group) severe
Hypoglycaemia severe
serious adverse events (various; judged unrelated in reports) severe

Drug interactions

doxorubicin major increases effect
5-fluorouracil major increases effect
epalrestat moderate increases effect
gliclazide moderate additive
cyclosporine moderate decreases effect
antipsychotics moderate additive
cisplatin moderate decreases effect
cyclophosphamide moderate decreases concentration
exemestane moderate increases effect
pregabalin moderate increases effect
Buy well

Recommended Alpha Lipoic Acid products

Real products that dose Alpha Lipoic Acid where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

In context

What this is and how it works

  • Across 6 studies (n=4,722), neuropathy symptoms improved, but average relief stayed below a noticeable-change threshold.2
  • The reviewed evidence spans 49 papers and 105 outcomes, with strongest support concentrated on neuropathy symptom relief.
  • Evidence primarily involves symptomatic diabetic polyneuropathy, limiting certainty for other neuropathy causes and populations.

Alpha lipoic acid is a sulfur-containing compound that your body makes in small amounts and uses inside cells that turn food into energy. Supplements provide much more than food normally supplies, usually as alpha lipoic acid, a blend of two mirror-image forms.1

Inside cells, alpha lipoic acid helps recycle antioxidant defenses that get used up during normal energy production.1 Think of it as a rechargeable cleanup crew: it helps restore the tools that clear reactive chemical debris before that debris adds stress to vulnerable nerve tissue.1

Bottom line

Alpha lipoic acid is most reasonable for someone seeking an additional option for neuropathy symptoms who understands that the average improvement is modest and often hard to feel.23 Skip the self-experiment approach if you take medicines with important interaction risks, especially glucose-lowering treatment or cancer therapies, and bring the decision to a clinician. The safety and interaction details deserve more attention here than promises of dramatic nerve-pain relief.

Frequently asked

Common questions

What does alpha lipoic acid do for neuropathy?

Trials in people with diabetic nerve damage show that oral alpha lipoic acid can reduce burning, tingling, and related symptoms, but the overall average benefit is small and often difficult to notice.23

How long does alpha lipoic acid take to work for nerve pain?

Shorter trials tracked symptom changes over roughly 3 to 16 weeks, while longer research followed participants for years. Give a consistent daily routine several weeks before judging your own response.23

Is R-alpha lipoic acid better than regular alpha lipoic acid?

R-alpha lipoic acid is one half of the alpha lipoic acid molecule, but the major neuropathy trials primarily used standard alpha lipoic acid preparations. That means standard alpha lipoic acid has the clearer clinical track record for this use.23

Sources

Sources

  1. 1. Alpha-lipoic acid as a biological antioxidant (1995)
  2. 2. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial (2006)
  3. 3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 4-year randomized controlled trial (2011)

Generated August 27, 2026